Poxel SAS announced the appointment of Khoso Baluch to its Board of Directors. Mr. Baluch will serve as an independent director and will further strengthen the Board by providing additional business strategy expertise on a worldwide basis. Khoso Baluch is senior vice president & President European Region at UCB, the global biopharmaceutical company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4645 EUR | -0.85% | -5.20% | -15.70% |
Apr. 11 | Poxel: CDC falls below the 10% threshold | CF |
Feb. 15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-15.70% | 24.61M | |
+20.44% | 125B | |
+22.05% | 114B | |
+25.30% | 26.73B | |
-23.30% | 19.43B | |
-18.10% | 16.22B | |
-18.89% | 15.33B | |
+10.66% | 14.42B | |
-48.41% | 14.33B | |
+56.24% | 14.2B |
- Stock Market
- Equities
- POXEL Stock
- News Poxel
- Poxel SAS Appoints Khoso Baluch to its Board of Directors